vs

Side-by-side financial comparison of CISO Global, Inc. (CISO) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.

CISO Global, Inc. is the larger business by last-quarter revenue ($6.3M vs $5.5M, roughly 1.1× Taysha Gene Therapies, Inc.). CISO Global, Inc. runs the higher net margin — -35.4% vs -507.8%, a 472.4% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs -15.4%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -11.6%).

CISO Global, Inc. is a specialized cybersecurity services provider. It offers managed security monitoring, risk assessment, compliance advisory and incident response, serving North American SMEs, government and commercial clients across healthcare, retail and finance to help safeguard digital assets and mitigate cyber risks.

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.

CISO vs TSHA — Head-to-Head

Bigger by revenue
CISO
CISO
1.1× larger
CISO
$6.3M
$5.5M
TSHA
Growing faster (revenue YoY)
TSHA
TSHA
+186.6% gap
TSHA
171.3%
-15.4%
CISO
Higher net margin
CISO
CISO
472.4% more per $
CISO
-35.4%
-507.8%
TSHA
Faster 2-yr revenue CAGR
TSHA
TSHA
Annualised
TSHA
26.8%
-11.6%
CISO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CISO
CISO
TSHA
TSHA
Revenue
$6.3M
$5.5M
Net Profit
$-2.2M
$-27.9M
Gross Margin
28.6%
Operating Margin
-33.7%
-516.0%
Net Margin
-35.4%
-507.8%
Revenue YoY
-15.4%
171.3%
Net Profit YoY
59.8%
-48.3%
EPS (diluted)
$0.10
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CISO
CISO
TSHA
TSHA
Q4 25
$6.3M
$5.5M
Q3 25
$6.5M
$0
Q2 25
$6.7M
$2.0M
Q1 25
$7.2M
$2.3M
Q4 24
$7.4M
$2.0M
Q3 24
$7.5M
$1.8M
Q2 24
$7.8M
$1.1M
Q1 24
$8.0M
$3.4M
Net Profit
CISO
CISO
TSHA
TSHA
Q4 25
$-2.2M
$-27.9M
Q3 25
$2.5M
$-32.7M
Q2 25
$-3.0M
$-26.9M
Q1 25
$-5.4M
$-21.5M
Q4 24
$-5.5M
$-18.8M
Q3 24
$-3.7M
$-25.5M
Q2 24
$-8.4M
$-20.9M
Q1 24
$-6.6M
$-24.1M
Gross Margin
CISO
CISO
TSHA
TSHA
Q4 25
28.6%
Q3 25
24.9%
Q2 25
24.4%
Q1 25
24.9%
Q4 24
24.8%
Q3 24
13.8%
Q2 24
12.0%
Q1 24
8.8%
Operating Margin
CISO
CISO
TSHA
TSHA
Q4 25
-33.7%
-516.0%
Q3 25
-40.8%
Q2 25
-34.7%
-1347.1%
Q1 25
-23.9%
-930.5%
Q4 24
-26.1%
-985.8%
Q3 24
-46.8%
-1448.4%
Q2 24
-54.3%
-1915.4%
Q1 24
-61.0%
-713.3%
Net Margin
CISO
CISO
TSHA
TSHA
Q4 25
-35.4%
-507.8%
Q3 25
39.2%
Q2 25
-44.8%
-1353.6%
Q1 25
-75.1%
-935.2%
Q4 24
-74.5%
-929.0%
Q3 24
-49.0%
-1427.5%
Q2 24
-108.0%
-1882.0%
Q1 24
-82.4%
-705.4%
EPS (diluted)
CISO
CISO
TSHA
TSHA
Q4 25
$0.10
$-0.08
Q3 25
$-0.05
$-0.09
Q2 25
$-0.09
$-0.09
Q1 25
$-0.38
$-0.08
Q4 24
$-0.47
$-0.07
Q3 24
$-0.32
$-0.10
Q2 24
$-0.69
$-0.09
Q1 24
$-0.55
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CISO
CISO
TSHA
TSHA
Cash + ST InvestmentsLiquidity on hand
$1.7M
$319.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$14.8M
$246.9M
Total Assets
$25.0M
$343.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CISO
CISO
TSHA
TSHA
Q4 25
$1.7M
$319.8M
Q3 25
$1.1M
$297.3M
Q2 25
$760.8K
$312.8M
Q1 25
$1.8M
$116.6M
Q4 24
$992.6K
$139.0M
Q3 24
$443.1K
$157.7M
Q2 24
$1.1M
$172.7M
Q1 24
$1.5M
$124.0M
Total Debt
CISO
CISO
TSHA
TSHA
Q4 25
Q3 25
$2.1M
Q2 25
$9.9M
Q1 25
$10.6M
Q4 24
$11.7M
Q3 24
$11.9M
Q2 24
$12.8M
Q1 24
$15.1M
Stockholders' Equity
CISO
CISO
TSHA
TSHA
Q4 25
$14.8M
$246.9M
Q3 25
$16.3M
$219.0M
Q2 25
$7.6M
$248.7M
Q1 25
$7.0M
$55.1M
Q4 24
$1.1M
$71.5M
Q3 24
$3.0M
$88.8M
Q2 24
$5.6M
$108.9M
Q1 24
$11.2M
$53.8M
Total Assets
CISO
CISO
TSHA
TSHA
Q4 25
$25.0M
$343.3M
Q3 25
$25.1M
$316.6M
Q2 25
$25.8M
$333.3M
Q1 25
$27.8M
$138.4M
Q4 24
$26.7M
$160.4M
Q3 24
$26.6M
$180.2M
Q2 24
$43.2M
$200.4M
Q1 24
$47.5M
$153.0M
Debt / Equity
CISO
CISO
TSHA
TSHA
Q4 25
Q3 25
0.13×
Q2 25
1.31×
Q1 25
1.52×
Q4 24
10.20×
Q3 24
3.92×
Q2 24
2.27×
Q1 24
1.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CISO
CISO
TSHA
TSHA
Operating Cash FlowLast quarter
$-1.8M
$-26.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CISO
CISO
TSHA
TSHA
Q4 25
$-1.8M
$-26.7M
Q3 25
$-876.7K
$-24.2M
Q2 25
$-2.3M
$-20.2M
Q1 25
$-3.0M
$-22.0M
Q4 24
$-259.0K
$-18.3M
Q3 24
$-903.1K
$-21.6M
Q2 24
$-1.3M
$-21.5M
Q1 24
$-1.4M
$-19.8M
Free Cash Flow
CISO
CISO
TSHA
TSHA
Q4 25
Q3 25
$-24.3M
Q2 25
Q1 25
Q4 24
$-18.3M
Q3 24
$-21.6M
Q2 24
$-1.3M
$-21.7M
Q1 24
$-1.5M
$-19.9M
FCF Margin
CISO
CISO
TSHA
TSHA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-905.5%
Q3 24
-1210.9%
Q2 24
-16.4%
-1951.9%
Q1 24
-18.5%
-584.5%
Capex Intensity
CISO
CISO
TSHA
TSHA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
0.1%
Q3 24
0.0%
2.0%
Q2 24
0.1%
18.1%
Q1 24
0.9%
4.1%
Cash Conversion
CISO
CISO
TSHA
TSHA
Q4 25
Q3 25
-0.35×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CISO
CISO

Security Managed Services$5.4M87%
Other$823.3K13%

TSHA
TSHA

Segment breakdown not available.

Related Comparisons